 | | Amprenavir (Agenerase) |  | | Published
January 25, 2001; Updated
December 04, 2007 | Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-03-05 | | | Selected Reference | | 6. | Piscitelli S, Bechtel C, Sadler B, Falloon J. The Addition of a Second Protease Inhibitor Eliminates Amprenavir-Efavirenz Drug Interactions and Increases Plasma Amprenavir Concentrations. Abstract 78. 7th Conference on Retroviruses and Opportunistic Infections. January 30-February 2, 2000; San Francisco. | |
|
|
|
